Dr. Yu's lab has extensively employed biochemical, cell biological, histological and mouse genetic approaches to define the role of post-translational modifications in mediating vascular development and vascular diseases. Also, Dr. Yu’s lab has developed clinical grade cellular products of perinatal stem cells and conducted correlated preclinical and clinical studies cooperating with physicians.